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Abstract
Introduction: Somatosensory evoked potential (SEP) recordings and continuous electroencephalography (EEG) are
important tools with which to predict Glasgow Outcome Scale (GOS) scores. Their combined use may potentially
allow for early detection of neurological impairment and more effective treatment of clinical deterioration.
Methods: We followed up 68 selected comatose patients between 2007 and 2009 who had been admitted to the
Neurosurgical Intensive Care Unit of Treviso Hospital after being diagnosed with subarachnoid haemorrhage (51
cases) or intracerebral haemorrhage (17 cases). Quantitative brain function monitoring was carried out using a
remote EEG-SEP recording system connected to a small amplification head box with 28 channels and a multimodal
stimulator (NEMO; EBNeuro, Italy NeMus 2; EBNeuro S.p.A., Via P. Fanfani 97/A - 50127 Firenze, Italy). For statistical
analysis, we fit a binary logistic regression model to estimate the effect of brain function monitoring on the
probability of GOS scores equal to 1. We also designed a proportional odds model for GOS scores, depending on
amplitude and changes in both SEPs and EEG as well as on the joint effect of other related variables. Both families
of models, logistic regression analysis and proportional odds ratios, were fit by using a maximum likelihood test
and the partial effect of each variable was assessed by using a likelihood ratio test.
Results: Using the logistic regression model, we observed that progressive deterioration on the basis of EEG was
associated with an increased risk of dying by almost 24% compared to patients whose condition did not worsen
according to EEG. SEP decreases were also significant; for patients with worsening SEPs, the odds of dying increased to
approximately 32%. In the proportional odds model, only modifications of Modified Glasgow Coma Scale scores and
SEPs during hospitalisation statistically significantly predicted GOS scores. Patients whose SEPs worsened during the last
time interval had an approximately 17 times greater probability of a poor GOS score compared to the other patients.
Conclusions: The combined use of SEPs and continuous EEG monitoring is a unique example of dynamic brain
monitoring. The temporal variation of these two parameters evaluated by continuous monitoring can establish
whether the treatments used for patients receiving neurocritical care are properly tailored to the neurological
changes induced by the lesions responsible for secondary damage.
Keywords: somatosensory evoked potentials, electroencephalographic monitoring, dynamic brain monitoring,
brain function monitoring
Introduction
Multimodality neuromonitoring has become increasingly
complex. Although advances in neuromonitoring have
provided insight into the pathophysiological and physio-
logical responses to therapy, beneficial effects on patients’
outcomes have not been definitively established. There
is increasing awareness that an aggressive intracranial
pressure (ICP)- and cerebral perfusion pressure (CPP)-
targeted approach may result in cardiorespiratory com-
plications [1].
A key limitation in the demonstration of monitoring
efficacy in neurocritical care is the complexity of treat-
ment generated by multimodality monitoring. A modern
neurocritical care unit can continuously monitor up to
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any medium, provided the original work is properly cited.10 to 20 interrelated physiological parameters. Assuming
that each parameter can be treated by using any of 10
possible interventions, the enormous potential number
of cointerventions represents a formidable challenge in
clinical trial design [2].
The application of continuous neurophysiological mon-
itoring with somatosensory evoked potentials (SEPs) and
electroencephalography (EEG) has an intuitive appeal, as
these techniques yield a direct measure of brain function
in patients whose neurological status might otherwise be
difficult to evaluate [3,4]. The early components of SEPs
are used in the acute phase of cerebral damage, when it is
difficult to assess the patient’s clinical status because of
the effect of sedatives, neuromuscular blockade or the
severity of coma. Short-latency SEPs are largely resistant
to analgo-sedation and have a waveform that is easily
interpretable and comparable in subsequent recordings.
They have peripheral, spinal, brainstem and intracortical
components which are always noticeable by exploring an
extended central nervous system (CNS) pathway. In the
absence of a relevant lesion along the afferent sensory
pathways, short-latency SEPs can provide a ‘global’ index
of brain function on the basis of brainstem, thalamocorti-
cal and intracortical transmission in both hemispheres.
The concept of secondary damage occurring after the
p r i m a r yn e u r o l o g i ci n j u r yw a sp o i n t e do u tb yR o s eet al.
[5] and later by Miller et al. [6], who reported that the
majority (91%) of patients experience secondary insults.
Increased ICP, hypotension and pyrexia are the most fre-
quently reported secondary insults. Moreover, several
investigators have reported ongoing transient and
dynamic changes in brain metabolism and neurochemis-
try after brain injury [7,8]. Continuous EEG monitoring
represents a valuable clinical tool with which to ‘detect
and protect’. It can detect seizures and protect the brain
from seizure-related injury in critically ill patients, in
whom the brain is often in a particularly vulnerable state.
The aim of the study was to find out the value of nonin-
vasive electrophysiological monitoring in predicting clini-
cal deterioration and final outcome in comatose patients
with SAH and/or ICH.
Materials and methods
We consecutively enrolled 68 selected comatose patients
admitted to the Neurosurgical Intensive Care Unit of
Treviso Hospital between 2007 and 2009 with a diagnosis
of subarachnoid haemorrhage (SAH) (51 cases) and/or
intracerebral haemorrhage (ICH) (17 cases). The inclu-
sion criteria were the presence of ICH or a Fisher Grade
3 or 4 SAH, a Glasgow Coma Scale (GCS) score ≤8a n d
the presence of an intracranial ICP-monitoring sensor.
Nineteen patients were excluded for different reasons:
non-neurological complications, patients lost to follow-
up and no family consensus for the patient to be included
in the study. The patients required sedation and con-
trolled ventilation for more than 24 hours. All patients
underwent initial brain computed tomography (CT) fol-
lowed by several follow-up scans. The bilateral absence
of the N20 response with median nerve stimulation at
SEPs was considered an exclusion criterion. The regional
ethics committee approved the study, and informed con-
s e n tw a so b t a i n e df r o mt h ep a t i e n t ’s closest relatives.
Patients with traumatic brain injury (TBI) were not
included in this study because the pathophysiology of
secondary damage after TBI is different from vascular
damage.
Quantitative brain function monitoring consisted of an
EEG-SEP recording system located far from the patient’s
bedside and connected by a serial interface to a small
amplification head box with 28 channels and a multimodal
stimulator (NEMO; EBNeuro, Italy) (Figures 1 and 2). The
acquired data were transmitted to a personal computer
(PC) by means of optical fibres. For each channel, the soft-
ware allows the user to set cycles of SEPs obtained by elec-
trical stimulation of the right and left median nerves at the
wrist. We used straight stainless steel needle electrodes.
The stimulus intensity was set above the motor threshold
(15 to 20 mA), the pulse duration was 0.2 milliseconds
and the stimulus frequency was 3 Hz. Electrodes were
placed at Erb’s point (referred to as the posterior muscle),
P3 and P4 (both referred to as Fz). The time base was 100
milliseconds, and the bandwidth was 5 Hz to 3 kHz. An
average of 200 responses were repeated and superimposed.
The length of the SEP session was set by using a user-
defined macro. We used a recording macro of 12 minutes
of SEP every 50 minutes. EEG results were continuously
recorded. The SEP traces were compared to a previously
recorded trace that was used as a template.
We started the session after manually locating the mar-
kers of the main waves (N20 latency and N20-P25 ampli-
tude). The software automatically recognises the N20 and
P25 peaks and puts the marker on the maximum negative
and positive deflections within a narrow window of ± 1
millisecond. The traces are displayed in cascades on one
side of the screen, while the trends of SEP latencies and
amplitudes are displayed on the other side. A horizontal
baseline represents the latency and amplitude of the tem-
plate, and latency and/or amplitude modifications make
the lines diverge from the baseline. Digital EEG results are
acquired by using eight electr o d e sa tt h eF 3 ,C 3 ,T 3 ,P 3 ,
F4, C4, T4 and P4 locations of the International 10-20 Sys-
tem of electrode placement. These are referred to as refer-
ence electrodes at the midpoint between Fz and Cz. The
needles are covered with a transparent plastic bandage.
According to the method Amantini et al.[ 9 ] ,S E P so n
each side were graded on a three-point scale. SEPs were
considered normal (N) if cortical complex N20-P25 ampli-
tude and central conduction time (CCT) were normal
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longed and/or N20-P25 amplitude was < 1.2 μVo rt h e
left-right amplitude asymmetry was > 50%; and absent (A)
if cortical responses were absent with preserved N11 (Erb’s
point). Taking into account the responses in both hemi-
spheres, six patterns were defined: NN, NP, PP, AN, AP
and AA. We used an EEG classification of coma based on
a modification of the method set forth by Synek et al.
[10,11]. A single expert electroencephalographer reviewed
and classified all the recordings as follows: IA = delta/theta
>50% reactivity; IB = delta/theta >50% without reactivity; II
= triphasic waves; IIIA = burst suppression with epilepti-
form activity; IIIB = burst suppression without epileptiform
activity; IV = alpha/theta/spindle coma nonreactive; VA =
epileptiform activity, generalised; VB = epileptiform activ-
ity, focal or multifocal, VIA = suppression < 20 μV, but >
10 μV; and VIB = suppression < 10 μV.
The EEG traces were displayed on one side of the
screen, and the quantitative electroencephalography
(QEEG) traces were displayed on the other side. QEEG
consists of both frequency (colour density spectral array
(CDSA)) and amplitude (percentage of burst suppression)
analysis. QEEG review immediately reveals right and left
hemispheric activity and significant EEG changes such as
seizures, worsening of focal slowing, generalised suppres-
sion and increasing or decreasing EEG frequency. ICP
was monitored with the use of an intraventricular cathe-
ter. ICP, cerebral perfusion pressure (CPP) and mean
arterial pressure (MAP) levels were stored in a database
file. Using these data, the peak ICP level and the time of
its occurrence were established for each patient during
the monitoring period. In patients with SAH, transcranial
Doppler (TCD) ultrasonography through the temporal
bone and eye windows was used to detect vasospasm and
direct the therapy. TCD monitoring with bilateral 2-MHz
probes and probe holders lasted at least 30 minutes per
day. Vasospasm was diagnosed when TCD mean veloci-
ties were > 120 cm/second, when there were daily
Figure 1 SEP continuous monitoring as displayed on the screen.
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when angiographic arterial narrowing was detected.
Patients were treated according to a standard protocol
including intravenous muscle relaxants, mechanical venti-
lation, osmotic diuresis and cerebrospinal fluid (CSF) drai-
nage with ICP values over 20 to 25 mmHg. All patients
underwent sedation with propofol and remifentanil infu-
sions at variable dosages to continuously record EEG and
SEPs. EEG is much more sensitive than SEPs to sedation.
At a sedation dosage higher than usual, we have some-
times noticed burst suppression on EEG without signifi-
cant modifications of SEP shape. Paralytics were used only
during some manoeuvres, such as tracheostomy or tra-
cheal tube change, or in cases of very unstable ICP. The
disappearance of muscle artefacts from the recordings was
their only effect on SEPs and EEG. None of the patients
received barbiturate infusions. We decided the respective
lengths of EEG and SEPs sessions on the basis of the clini-
cal features. We kept monitoring until the monitored
parameters were stable and the patient was no longer con-
sidered at risk of developing brain complications. Acquired
data were saved on the recording remote PC used as a ser-
ver. A follow-up telephone interview was conducted at
least three months after the patient’s discharge from the
hospital. Patient outcomes were assessed using the five-
point Glasgow Outcome Scale (GOS) [12].
Statistical analysis
The marginal effect of each available variable on GOS
s c o r ea n dm o r t a l i t yw a se v a l u a t e db yu s i n gu n i v a r i a t e
measures of association. Associations were tested by
using an analysis of variance F-test for quantitative vari-
ables (age and duration) and Pearson’s c
2 test for cate-
gorical variables. To study the association with
mortality, we used Fisher’se x a c tt e s tw h e nb i n a r yv a r i -
ables were involved.
However, our aim was to assess the ability of SEPs
and EEG monitoring to predict GOS scores, with a
Figure 2 QEEG continuous monitoring as displayed on the screen. At the top, the raw EEG data are shown. At the bottom, the CDSA
spectrogram shows averaged root EEG power from 0 to 32 Hz (y-axis) derived from consecutive 10-second EEG epochs (each composed of five
2-second windows) obtained from F3-C3 and F4-C4. The power amplitude is expressed as a colour scale.
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other coexisting variables. For this reason, we fit a pro-
portional odds model whereby the ratio of the probabil-
ity of observing a particular GOS score and the
probability of observing a lower score depended on the
values and changes in SEPs and EEG results, also taking
into account the joint effect of other related variables
[13]. We also fit a binary logistic regression model to
estimate the effect of monitors on the probability of
dying (GOS score = 1) [13]. Both models, logistic
regression analysis and proportional odds ratio, were fit
by using the maximum likelihood test, and the partial
effect of each variable was assessed by using the likeli-
hood ratio test. To simplify the statistical analysis, we
selected and analysed three time points: beginning, mid-
dle and end (times 1, 2 and 3, respectively). Receiver
operating characteristic (ROC) curves were compared by
applying DeLong’s test [14].
Results
A total of 68 patients (34 males and 34 females; mean age
(± standard deviation (SD)), 53.19 ± 14.44 years; age
range, 18 to 83 years) were monitored with continuous
EEG-SEPs for an average (± SD) of 10 ± 4 days and were
included in the study. We observed that SEPs never
showed latency or amplitude modification in clinically
stable patients. Conversely, whenever neurological dete-
rioration was detected on the basis of a decrease in GCS
score (20 patients, 29.4%), SEPs always showed a signifi-
cant latency increase and amplitude decrease. In these
patients, the EEG-SEP worsening was not correlated with
an immediate ICP increase (see Figures 3 and 4 for exam-
ples of EEG-SEP worsening). In 16 of 20 patients, EEG-
SEP worsening appeared 24 to 48 hours before ICP
increase. These patients developed angiographic vasos-
pasms with ischemic lesions visualized on CT scans. EEG-
SEP worsening appeared after ICP increase in four
patients with brain swelling documented on serial CT
scans. In the first 16 patients, EEG analysis showed non-
convulsive seizures with periodic discharges and rhythmic
delta activity within 48 hours before a TCD- and angiogra-
phy-documented vasospasm. After EEG epileptiform dis-
charge, SEPs showed amplitude instability, with
fluctuations > 50% both above and below the baseline
amplitude, with a final reduction or disappearance of cor-
tical SEPs. These patients had documented cortical ischae-
mia detected by serial CT scans (Table 1).
I nT a b l e2 ,w es h o wt h eP values calculated on the
basis of univariate association tests. We included all the
available variables in the logistic regression model: age,
sex, initial observed EEG and SEPs levels, each dichoto-
mised decrease of EEG and SEP levels, ICP, available
treatment and clinical variables during hospitalisation,
and the extent of the observation time. With regard to
ICP, we grouped the patients according to the highest
ICP values recorded during the monitoring time,
namely, ICP < 20 mmHg, 20 mmHg < ICP < 40 mmHg,
and ICP > 40 mmHg. We selected the variables by
using a forward stepwise procedure according to the
Aikake information criterion (AIC) [15]. The results of
the final model are summarized in Table 3. As the dif-
ferences between ICP < 20 mmHg and 20 mmHg < ICP
< 40 mmHg were not significant (P > 0.05), we merged
the two groups. The overall fit of this model is quite
good, since the goodness-of-fit c
2 statistics are 47.87 on
62 degrees of freedom, giving a P value of 0.9.
On the basis of the obtained estimates, when the EEG
results worsened during the time of observation, the
patients’ odds of dying increased by about 24% compared
with similar patients whose conditions had not worsened.
SEP decreases were also significant. Patients with worsen-
ing SEPs had increased odds of dying about 32% greater
than similar patients whose conditions had not worsened.
Moreover, the longer the duration of hospitalisation, the
lower the risk of dying. Each day of hospitalisation
decreased the odds of dying by about 50%.
To assess whether the inclusion of EEG and SEP varia-
tions in the model improved outcome prediction, we com-
pared ROC curves of four models: the final model,
including both EEG and SEPs variations; the two models
obtained by removing either EEG or SEP variations,
respectively; and the model fitted by removing both EEG
and SEP variations. The contribution of both variables was
clearly important in predicting which patients will die
(Figure 5). The joint contribution of both variables was
significant (P = 0.046 for comparisons between ROC
curves), even if each variable alone did not seem to be sig-
nificant (P = 0.21 without considering EEG variation and
P = 0.15 without considering SEP variation).
Table 4 illustrates the coefficients of variation and P
values derived by using the proportional odds model. As
for the logistic regression model, we selected the most
significant variables by using a forward stepwise proce-
dure with the AIC. Since very few patients showed GOS
scores of 2 and 5, we aggregated them with GOS scores
of 3 and 4, respectively. Therefore, we obtained a three-
level (1 = dead, 2-3 = poor score, 4-5 = good score)
GOS score.
T h i sm o d e la l s oh a sag o o df i tt ot h ed a t a .T h ec
2
goodness-of-fit statistic is 85.86 on 131 degrees of free-
dom, giving a P value of almost 1. Only modifications of
the Modified GCS (GCS-M) and SEPs during hospitalisa-
tion were significant in predicting the GOS score.
Patients showing worsening SEPs during the last time
interval were less likely (1 in 20 probability) of having a
higher GOS score than patients with stable SEPs. Patients
with a worsening GCS-M score during the entire obser-
vational period had a 1% probability of having a high
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scores. Moreover, patients with improving GCS-M scores
had an approximately 14 times greater probability than
patients with worsening GCS-M scores of having a high
GOS score (Table 4).
We also tested a model excluding the GCS-M modifi-
cations in relation to time. However, it did not fit as
well, showing the importance of GCS-M changes during
hospitalisation. It is interesting to observe that the initial
SEP level and its changes during hospitalisation, the
changes in EEG results in the last period of observation
and the presence of ICP > 40 mmHg were significant
variables when GCS-M was not considered, similarly to
the results we obtained with the logistic regression
model.
It is worth noting that demographic variables such as
age and sex were not significant in any of the models
used to predict GOS scores. They were not significant
even when considered alone (Table 2). The treatments
effect was not significant in association with the other
variables or when considered alone (Table 2).
Discussion
Continuous EEG-SEP monitoring is a relatively new, non-
invasive bedside monitoring tool that allows functional
measurement of neurological impairment. Despite the fre-
quent use of high-level neurosedation, it is always possible
to monitor critical SEP changes. Even untrained personnel
can easily interpret the simple waveforms of raw SEPs,
while raw EEG analysis always requires a neurophysiolo-
gist. Moreover, SEP trends are based on two simple para-
meters: amplitude and latency. Amplitude decrease and
latency increase are dependent on the physiopathology of
brain damage. Amplitude is related to the number of fibres
carrying the signal to the primary somatosensory cortex. In
the CNS, latency is mainly associated with white matter
Figure 3 Example of EEG-SEP worsening. In the top left panel, SEPs are presented at a precise moment which corresponds to the pink line
on the raw EEG image (top right panel), with periodic epileptiform activity shown on the QEEG image (bottom right panel) expressed with the
CDSA spectrogram, and on the image showing the temporal trend of SEP amplitude (bottom left panel). Note how a progressive loss of SEPs
preceded by amplitude instability follows the periodic epileptiform activity.
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Page 6 of 11swelling. In the peripheral nervous system, it is related to
temperature and focal myelin dysfunction. There is good
evidence that serial SEP studies have provided useful infor-
mation about the functional recovery of impaired areas
[16,17]. This is particularly true during the early postinjury
stage, as SEPs are a sensitive measure of secondary damage.
Our results clearly show that SEPs frequently change
over time. In our series, the SEP-EEG deterioration was
probably related to many different pathogenetic
mechanisms. In patients with ischaemia following vasos-
pasm, SEP modifications preceded the ICP increase by
24 to 48 hours (16 patients). In patients with brain
oedema without hypoxic damage, SEP modifications
appeared later (four patients). The most likely explana-
tion for this temporal sequence of events is that
uncontrollable ICP may simply be a sign of large
volumes of nonviable brain tissue in patients who even-
tually die as a result of their brain injuries [18]. Contin-
uous SEP monitoring has strong prognostic power
because amplitude modifications usually precede clinical
manifestation of functional integrity. As continuous SEP
monitoring reveals the potential for recovery, it can
sometimes direct the physician towards more aggressive
clinical management. SEPs provide important informa-
tion about patients who are pharmacologically paralysed
and sedated to help with their ventilation and ICP man-
agement. In this setting, we have frequently relied on
SEP measurement to direct the therapy implemented.
We discourage aggressive treatment (barbiturate-
induced coma and decompressive craniectomy) to con-
trol refractory ICP in patients who have lost cortical
SEP activity. Other investigators have also observed the
absence of correlation between increased ICP and SEP
deterioration. Focal injury results in primary damage to
neurons and the surrounding cerebral vessels. The sec-
ondary damage is due to ischaemia and the cytotoxic
cascade. Cytotoxic and vasogenic oedema in neurons
leads to excitotoxic swelling. SEP deterioration can have
different timing, and it can occur before or after an
increase in ICP. ICP Trends in our patients did not
Figure 4 Example of EEG-SEP worsening. SEP disappearance in the left hemisphere, corresponding to rhythmic lateralized delta activity
shown on the raw EEG and on the QEEG-CDSA spectrogram (pink lines).
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Page 7 of 11Table 1 Temporal analysis of ICP and EEG worsening related to ICP increase, vasospasm and CT scan ischaemic evidence
a
Event Number of
patients
Stable
SEPs
SEPs decrease
before ICP increase
SEPs decrease after
ICP increase
Number of
vasospasms
Epileptiform discharge (periodic discharges, rhythmic
delta activity, spike wave or sharp wave)
Increase in ICP
>2 5m m H g
CT scan
secondary
damage
SAH, n
(%)
51 (75%) 35
(68.6%)
16 (31.4%) 0 16 (31.4%) 18 (35.2%) 27 (52.9%) 18 ischaemic
lesions
ICH, n
(%)
17 (25%) 13
(76,5%)
0 4 (23.5%) 0 6 (40%) 12 (70.5%) 12 mass effects
Total,
n (%)
68 (100%) 48
(70.6%)
16 (23.5%) 4 (5.9%) 18 (26.4%) 24 (35.2%) 39 (57.3%) 30 (48.5%)
aCT: computed tomography; EEG: electroencephalography; ICH: intracranial haemorrhage; ICP: intracranial pressure; SAH: subarachnoid haemorrhage; SEPs: somatosensory evoked potentials.
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1demonstrate a clear seizure-related effect on ICP or CPP
in the hours directly before or during a seizure. ICP
usually increased after vasospasm. Vasospasm is a pri-
mary source of neurologic comorbidity after SAH. TCD
ultrasonography and cerebral angiography cannot be
continuously performed; in contrast, EEG and SEPs can
be used to constantly monitor cerebral activity.
In our series, the most sensitive QEEG monitoring
parameter in detecting seizures was CDSA. Seizures are
often associated with transient increases in EEG power,
although they have to be confirmed with the review of
the raw EEG. Similarly, QEEG should never be inter-
preted without reviewing portions of the original wave-
forms. Most epileptiform activity in our patients
occurred in the form of repetitive sharp waves. This
activity shows a clear related predictive effect on vasos-
pasm 24 to 48 hours in advance of vasospasm itself.
QEEG data can be displayed using many methods
[19-21]. CDSA depicts ictal and interictal data after a
quantitative transformation of raw EEG data (Figure 2).
Time is displayed on the x-axis. The upper graph,
labelled ‘F F T _ s p e c t r o g r a m0t o3 2l e f ta v g ’,i sac o l o u r
spectrogram showing averaged root EEG power from 0
to 32 Hz (y-axis) created from consecutive 10-second
EEG epochs (each composed of five 2-second windows)
obtained from F3-C3 and F4-C4. The patient’s repetitive
seizures are clearly shown on the spectrogram as vertical
bands of increased power. These graphs usually express
power amplitude on a colour-coded scale. Amplitude-
integrated EEGs can also provide a reasonable indication
of the presence of suppression burst activity. The SEPs
not only have a strong predictive power on outcome but
also serve as a feedback tool with which to modify and
correct treatment according to the correlated neurologi-
cal instability. If SEPs are stable, then the patient is neu-
rologically stable even though ICP and CPP values are
not in the normal range. Moreover, SEPs can be patho-
logical despite normal ICP and CPP values; in this case,
Table 2 P value univariate association measures
a
Variable Association with GOS Association with mortality
Age 0.637 0.363
Duration 0.253 0.037
Gender 0.488 0.183
GCS-M < 0.001 < 0.001
EEG initial 0.717 0.205
EEG second 0.747 0.214
EEG final 0.136 0.002
SEPs initial 0.001 0.514
SEPs second 0.002 0.152
SEPs final < 0.001 < 0.001
EEG from first to second time interval (worsened) 0.766 0.349
EEG from second to third time interval (worsened) 0.012 0.001
EEG from first to third time interval (worsened) 0.005 0.001
SEPs from first to second time interval (worsened) 0.227 0.221
SEPs from second to third time interval (worsened) < 0.001 < 0.001
SEPs from first to third time interval (worsened) 0.001 < 0.001
Embolisation 0.275 0.734
Craniotomy 0.252 1
Decompressive craniotomy 0.407 0.215
ICP 0.007 < 0.001
aEEG: electroencephalography; GCS-M: Modified Glasgow Coma Scale; GOS: Glasgow Outcome Scale; ICP: intracranial pressure; SEPs: somatosensory evoked
potentials.
Table 3 Summary of final logistic regression model for the probability of GOS score 1
a
Variable Coefficient estimate P value Odds ratio
Intercept -6.1706 0.034 0.002
Age 0.0914 0.040 1.096
ICP > 40 mmHg 6.5074 0.006 670.1
Duration (days) -0.5866 0.020 0.556
EEG from first to third observation (worsened) 3.1839 0.028 24.14
SEPs from first to third observation (worsened) 3.4769 0.005 32.36
aEEG: electroencephalography; GOS: Glasgow Outcome Scale; ICP: intracranial pressure; SEPs: somatosensory evoked potentials.
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reestablish normal SEP values.
Conclusions
As SEP monitoring shows high correlation with patient
outcome, it provides a measurable level of initial damage
based on the template SEP baseline and on measurable
parameters such as amplitude and latency. The temporal
variation of these two parameters, evaluated on the basis
of continuous monitoring, can confirm whether the treat-
ment is tailored to the neurological changes induced by
the lesion responsible for the secondary damage. The find-
ings of this single-centre study show that SEP worsening is
independently associated with a poor outcome in coma-
tose patients after ICH. It is measured by specific para-
meters that quantify the damage, and it replaces clinical
data that are often not quantifiable because of both patient
sedation and the subjective evaluation by the physician.
Precocious SEP deterioration can detect neurological
impairment earlier than other haemodynamic variables
such as ICP and CPP, allowing improvement of the treat-
ment used. However, it is not always possible to block the
pathophysiological process, despite its early identification.
In patients with SAH, the early changes in SEP amplitude
allow timely detection of initial vasospasm. The combined
use of SEPs and continuous EEG monitoring is a unique
example of dynamic brain monitoring.
Key messages
￿ Continuous SEPs and EEG allow for evaluation
over time of cerebral function in comatose patients.
￿ Continuous SEPs and EEG findings are indepen-
dently associated with three-month outcomes.
￿ EEG and SEPs predict worsening of outcome inde-
pendently of ICP.
￿ Continuous SEPs that change over time provide
useful information about secondary insults and
recovery of function.
￿ QEEG monitoring is the best method for recognis-
ing seizures over time.
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